Superantigen activation of CD4+ and CD8+ T cells from HIV-infected subjects: Role of costimulatory molecules and antigen-presenting cells (APC)

Clinical and Experimental Immunology

Volumn 111, Issue 1, 1998, Pages 12-19

  Vingerhoets, J ^a   Dohlsten, M ^b   Penne, G ^a   Colebunders, R ^a   Sansom, D ^c   Bosmans, E ^d   Kestens, L ^a   Vanham, G ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b LUND UNIVERSITY   (Sweden)

^c Bath Institute for Rheumatic Diseases   (United Kingdom)

^d Eurogenetics   (Belgium)

Author keywords

Apoptosis; Costimulation; HIV infection; Superantigen; T cells

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; STAPHYLOCOCCUS ENTEROTOXIN A; SUPERANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CHO CELL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHO CELLS; CRICETINAE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; SUPERANTIGENS;

EID: 0031905325     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00465.x     Document Type: Article

References (45)

1. Schwartz RH. Costimulation of T lymphocytes: the role of CD28. CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71:1065-8.
2. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T-cell responses to antigen. Annu Rev Immunol 1993; 11:191-212.
3. Janeway CAJ, Golstein P. Lymphocyte activation and effector functions. Editorial overview. The role of cell surface molecules. Curr Opin Immunol 1993; 5:313-23.
4. Bierer BES, Herrmann S, Burakoff SJ. Interaction of CD2 with its ligand, lymphocyte function-associated antigen-3, in human T cell proliferation. J Immunol 1988; 140:3358-63.
5. Koyasu S, Lawton T, Novick D et al. Role of interaction of CD2 molecules with lymphocyte-function associated antigen 3 in T-cell recognition of nominal antigen. Proc Natl Acad Sci USA 1990; 87:603-7.
6. Gajewski TF, Schell SR, Nau G, Fitch FW. Regulation of T-cell activation: differences among T-cell subsets. Immunol Rev 1989; 111:79-110.
7. Dellabona P, Peccoud J, Kappler J, Marrack P, Benoist C, Mathis D. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 1990; 62:1115-21.
8. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248:705-11.
9. Fraser JD. High affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 1989; 339:221-3.
10. Fisher H, Dohlsten M, Lindvall M, Sjögren HO, Carlsson R. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines. J Immunol 1989; 142:3151-7.
11. Mollick JA, Cook RG, Rich RR. Class II MHC molecules are specific receptors for Staphylococcus Enterotoxin A. Science 1989; 244: 817-20.
12. + T-cell subsets. Scand J Immunol 1992; 36:243-9.
13. + T lymphocytes with B7 and lymphocyte function-associated antigen-3 results in distinct cell activation profiles. J Immunol 1994; 153:2479-87.
14. Parra E, Wingren AG, Hedlund G et al. Human naive and memory T-helper cells display distinct adhesion properties to ICAM-1, LFA-3 and B7 molecules. Scand J Immunol 1993; 38:508-14.
15. + T cells require a costimulatory signal mediated through the LFA-1/ICAM-1 pathway. J Immunol 1992; 148:1993-8.
16. Parra E, Wingren AG, Hedlund G, Kalland T, Dohlsten M. The role of B7-1 and LFA-3 in costimulation of CD8(+)Tcells. J Immunol 1997; 158:637-42.
17. Fahey JL, Taylor JMG, Detels R et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990; 322:166-72.
18. Miedema F, Petit AJC, Terpstra FG et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. J Clin Invest 1988; 82:1908-14.
19. Clerici M, Stocks NI, Zajac RA et al. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J Clin Invest 1989; 84:1892-9.
20. + CD8 cell subsets during in vitro culture of mononuclear cells from human immunodeficiency virus type-1 (HIV)-seropositive tonner blood donors. J Clin Immunol 1989; 9:421-8.
21. Gougeon ML, Lecoeur H, Dulioust A et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons - increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996; 156:3509-20.
22. Borthwick NJ, Bofill M, Gombert WM et al. Lymphocyte activation in HIV-1 infection. II. Functional defects of CD28 T-cells. AIDS 1994; 8:431-41.
23. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996; 10:F17-F22.
24. Kestens L, Vanham G, Gigase P et al. Expression of activation antigens, HLA-DR and CD38 on CD8 lymphocytes during HIV-1 infection. AIDS 1992; 6:793-7.
25. Kestens L, Vanham G, Vereecken C et al. Selective increase of activation antigens HLA-DR and CD38 on CD4 (+) CD45RO (+) T lymphocytes during HIV-1 infection. Clin Exp Immunol 1994; 95: 436-41.
26. Meyaard L, Schuitemaker H, Miedema F. T-cell dysfunction in HIV infection - anergy due to defective antigen-presenting cell function. Immunol Today 1993; 14:161-4.
27. Vingerhoets JH, Vanham GL, Kestens LL et al. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8 (+) T cells from HIV-infected subjects. Clin Exp Immunol 1995; 100:425-33.
28. Gruters RA, Terpstra FG, de Goede REY et al. Immunological and virological markers in individuals progressing from seroconversion to AIDS. AIDS 1991; 5:837-44.
29. - cell population in the blood and lung of HIV-positive patients. J Acquir Immun Defic Syndr 1993; 6:1194-204.
30. Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J Infect Dis 1994; 169:730-8.
31. Eylar EH, Riveruquinones C, Laroche HI, Yamamura Y. Proliferative response of CD4 (+) and CD8 (+) T cell subsets from hispanics with HIV+ and AIDS - the superantigen hypothesis. J Acquir Immun Defic Syndr 1994; 7:124-8.
32. CDC 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41:1-17.
33. Hedlund G, Dohlsten M. Herrmann T et al. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells. J Immunol 1991; 147:4082-5.
34. + T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects. Clin Exp Immunol 1997; 107:440-7.
35. Li X, Darzynkiewicz Z. Labelling DNA strand breaks with BrdUTP. Detection of apoptosis and cell proliferation. Cell Prolif 1995; 28: 571-9.
36. Baroja ML, Ceuppens JL. More exact quantification of interleukin-2 production by addition of anti-Tac monoclonal antibody to cultures of stimulated lymphocytes. J Immunol Methods 1987; 98:267-70.
37. Imberti L, Sottini A, Bettinardi A, Puoti M, Primi D. Selective depletion in HIV infection of T-cells that bear specific T-cell receptor-Vbeta sequences. Science 1991; 254:860-2.
38. Dalgleish AG, Wilson S, Gompels M et al. T-cell receptor variable gene products and early HIV-1 infection. Lancet 1992; 339:824-8.
39. Laurence J, Hodtsev AS, Posnett DN. Superantigen implicated in dependence of HIV-1 replication in T cells on TCR Vbeta expression. Nature 1992; 358:255-9.
40. + T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994; 370:463-7.
41. Sundstedt A, Hoiden I, Hansson J, Hedlund G. Kalland T, Dohlsten M. Superantigen-induced anergy in cytotoxic CD8 (+) T cells. J Immunol 1995; 154:6306-13.
42. + T-cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992; 175:331-40.
43. Garcia S, Dadaglio G, Cilote V, Chenal H, Bondurand A, Gougeon ML. Evidence for an in vivo superantigenic activity in human immunodeficiency virus-infected individuals. Blood 1996; 88:2151-61.
44. Ott M, Emiliani S, Van Lint C et al. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science 1997; 275:1481-5.
45. + T lymphocytes during HIV infection. J Immunol 1996; 156:2282-93.